EUVIMEDEUVIMED entdecken
Open Access

Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis

Bochra Tourki iD, Minxue Jia, Theodoros Karampitsakos, Iset M Vera, Alyssa Arsenault, Zainab Fatima, Carole Y Perrot iD, Dylan Allen, Forouzandeh Farsaei, David Rutenberg, Debabrata Bandyopadhyay, Ricardo Restrepo-Jaramillo und 8 weitere

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00528.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Bochra Tourki und 19 weiteren Autor:innen. Beteiligte Einrichtung: Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Morsani Coll…. Hauptthemen laut MEDLINE: COVID-19, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, USF | Morsani College of Medicine (MCOM), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in the 50-gene signature, reflective of increase in CD14 + HLA-DR low CD163 + monocytes and decrease in CD4 and CD8 T cells, are associated with increased mortality in COVID-19. A reversal of this pattern can be seen in post-COVID-19-ILD, whereas its persistence can be seen in IPF. Modulating the imbalance between HLA-DR low monocytes and T cell subsets should be investigated as a potential strategy to treat pulmonary fibrosis associated with severe COVID-19 and progressive IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Idiopathic Pulmonary FibrosisLung Diseases, InterstitialHumansMaleFemaleMiddle AgedAgedSARS-CoV-2Leukocytes, MononuclearBiomarkersCytokinesLipopolysaccharide ReceptorsCD8-Positive T-LymphocytesTranscriptome

Stichwörter der Autor:innen

50-gene signature7Gene-M-MDSCsCOVID-19IPFpost-COVID-19-ILD

Substanzen

BiomarkersCytokinesLipopolysaccharide Receptors

Autor:innen und Institutionen

  • Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United S…
  • Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
  • Joint Carnegie Mellon-University of Pittsburgh Computational Biology Ph.D. Program, Pittsburgh, Pennsylvania, United States.
  • Division of infectious Disease, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
  • Center for Advanced Lung Disease and Lung Transplant Program, Tampa General Hospital, Florida, United States.
  • Department of Respiratory Medicine, University of Patras, Patras, Greece.

ORCID-Profile: Bochra Tourki, Carole Y Perrot, Muhammad R Qureshi, Jose D Herazo-Maya

Förderung

  • NHLBI NIH HHS
  • USF | Morsani College of Medicine (MCOM)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)

Zitieren

APA

Tourki, B., Jia, M., Karampitsakos, T., Vera, I. M., Arsenault, A., Fatima, Z., Perrot, C. Y., Allen, D., Farsaei, F., Rutenberg, D., Bandyopadhyay, D., Restrepo-Jaramillo, R., Qureshi, M. R., Patel, K., Tzouvelekis, A., Kapetanaki, M. G., Juan-Guardela, B. M., Kim, K., Benos, P. V., & Herazo-Maya, J. D. (2025). Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00528.2024

Vancouver

Tourki B, Jia M, Karampitsakos T, Vera IM, Arsenault A, Fatima Z, et al. Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00528.2024

BibTeX
@article{Tourki2025,
  author = {Tourki, Bochra and Jia, Minxue and Karampitsakos, Theodoros and Vera, Iset M and Arsenault, Alyssa and Fatima, Zainab and Perrot, Carole Y and Allen, Dylan and Farsaei, Forouzandeh and Rutenberg, David and Bandyopadhyay, Debabrata and Restrepo-Jaramillo, Ricardo and Qureshi, Muhammad R and Patel, Kapilkumar and Tzouvelekis, Argyris and Kapetanaki, Maria G and Juan-Guardela, Brenda M and Kim, Kami and Benos, Panayiotis V and Herazo-Maya, Jose D},
  title = {Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00528.2024}
}
Kostenlos starten →